BIOSIMULYTICS
BioSimulytics develops AI-powered software for drug researchers.
BIOSIMULYTICS
Social Links:
Industry:
Artificial Intelligence Machine Learning Pharmaceutical Software
Founded:
2019-01-01
Address:
Dublin, Dublin, Ireland
Country:
Ireland
Website Url:
http://www.biosimulytics.ai
Total Employee:
1+
Status:
Active
Total Funding:
595 K EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager Global Site Tag Amazon Google Apps For Business Cloudflare JS
Similar Organizations
35up
Bringing Embedded Cross-Selling into every online checkout.
Mimica Automation
Mimica watches you work and learns to automate your most repetitive tasks.
Pera Labs
Pera Labs develops digiceuticals and AI-powered solutions for fertility.
Current Employees Featured
Founder
Investors List
Enterprise Ireland
Enterprise Ireland investment in Seed Round - BioSimulytics
Official Site Inspections
http://www.biosimulytics.ai
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "BioSimulytics"
BioSimulytics - AI-enhanced molecular modelling
Boosting success rates in Pharma R&D through the predictive power of AI-enhanced molecular modelling. BioSimulytics has developed breakthrough technology combining quantum physics, computational chemistry, machine …See details»
BioSimulytics - Crunchbase Company Profile & Funding
BioSimulytics develops AI-powered software for drug researchers. M2M-CSP: A solution for predicting crystal structures, enhancing speed and certainty in …See details»
BioSimulytics Company Profile 2024: Valuation, Funding
BioSimulytics General Information Description. Developer of an AI-enhanced predictive platform designed to assist pharmaceuticals with the development of drugs. The company's platform …See details»
Biosimulytics | EIT
Biosimulytics (Ireland), is developing a quantum physics-based, AI/ML-powered pharmatech platform to improve the speed, scale, novelty and success rate of drug development.The company has received tremendous support through …See details»
biosimulytics - LinkedIn
Biosimulytics is a deep-tech spin-out from University College Dublin’s School of Chemical & Bioprocess Engineering, founded in 2019. We specialize in leveraging cutting-edge AI, advanced neural ...See details»
Next-generation digital platform for faster, more accurate and …
BioSimulytics provides a unique software solution using neural network technology and high performance computing for the accurate prediction of crystal structures of new drug molecules …See details»
BioSimulytics - Company Profile - Tracxn
Nov 1, 2024 BioSimulytics - Provides AI-enhanced molecular modelling platform for biopharma sector. Raised a total funding of $709K over 3 rounds from 3 investors. Founded by Peter F …See details»
BioSimulytics - EU-Startups
BioSimulytics was formed in November 2019 as a spin-out company from the School of Chemical and Bioprocess Engineering at University College Dublin (UCD), Ireland. The company is backed by a combination of national funding …See details»
BioSimulytics Reviews, Funding, Founder, Valuation & Jobs
Find out if BioSimulytics is hiring now! Explore jobs, salary, equity, funding, founder, and valuationn information. Read about work-life balance, perks, benefits, and the company …See details»
BioSimulytics - Recent News & Activity - Crunchbase
Feb 20, 2024 Organization. BioSimulytics . Connect to CRM . Save . Go back to BioSimulytics's Signals & News . Recent News & Activity. Edit Recent News & Activity Section. Number of …See details»
BioSimulytics - Products, Competitors, Financials, Employees ...
CGG Awarded Exclusive Contract to Provide HPC Cloud Solutions to Biosimulytics for AI-powered Drug Development. May 4, 2023. 05/04/2023 | 01:32am EDT Message : Paris, …See details»
NovaUCD’s BioSimulytics raises €595,000 of seed capital
Sep 2, 2021 University College Dublin (UCD) spin-out BioSimulytics has closed a seed funding round worth €595,000. The start-up is based in NovaUCD and is developing AI-based …See details»
BioSimulytics | Scientist.com
Scientist.com is the world’s largest AI-powered marketplace for medical research. ... biosimulytics.ai: Headquarters: Dublin, , IE Company Type: New Startup (0-1M TTM Revenue) …See details»
Pharma AI Firm BioSimulytics Secures €595K in Seed Funding
Sept. 3, 2021 -- BioSimulytics, a University College Dublin (UCD) spin-out company, announced that it has secured €595K ($707K USD) in initial seed funding from a number of strategic angel …See details»
NovaUCD’s BioSimulytics becomes 2024 EIT Awards finalist
Feb 16, 2024 BioSimulytics was nominated for this year’s EIT Innovation Team Award for its AI-based software that aims to boost the speed and success of drug development. University …See details»
Making it Work: Pharma software firm BioSimulytics aims to help ...
Sep 3, 2021 BioSimulytics, a Dublin-headquartered start-up, has just raised more than half a million euro and plans to become a global player in a rapidly growing industry. The company, …See details»
Biosimulytics Named a 2024 EIT Awards Finalist
Biosimulytics is developing a quantum physics-based, AI/ML-powered pharmatech platform to improve the speed, scale, novelty and success rate of drug development. The technology …See details»
NovaUCD’s BioSimulytics becomes 2024 EIT Awards finalist
Feb 16, 2024 In 2019, BioSimulytics was named as the winner of the UCD VentureLaunch accelerator programme. Two years later, the start-up closed a seed funding round worth …See details»
BioSimulytics Locations - Contract Research Map
NovaUCD Belfield Innovation Park University College Dublin Dublin, D04 V2P1 Ireland BioSimulytics is developing a quantum physics-based, AI/ML-powered pharmatech platform …See details»
10 Good Questions to Ask a Nonprofit Organization for Impact
Oct 28, 2024 This not only helps the organization but also enriches the community as more people get involved in meaningful work. Asking about volunteer opportunities allows …See details»